Macomics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$14.8M
- Investors
-
6
Macomics General Information
Description
Developer of precision medicines designed to modulate macrophages for the treatment of cancer. The company's medicines target the immunosuppressive tumor microenvironment, which exploits disease-specific macrophage biology to harness the power of the immune system, enabling medical practitioners and pharma companies to give clinical benefits to many more patients suffering from cancer.
Contact Information
Website
www.macomics.comCorporate Office
- The University of Edinburgh, Campus Service Centre
- Roslin Innovation Centre, Easter Bush Campus
- Edinburgh EH25 9RG
- Scotland, United Kingdom
Corporate Office
- The University of Edinburgh, Campus Service Centre
- Roslin Innovation Centre, Easter Bush Campus
- Edinburgh EH25 9RG
- Scotland, United Kingdom
Macomics Timeline
Macomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 21-Oct-2026 | $14.8M | Completed | Generating Revenue | ||
| 5. Later Stage VC | 01-Mar-2023 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 21-Jul-2021 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 14-Jul-2020 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 06-Nov-2018 | Completed | Startup |
Macomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series 4 Seed | ||||||||
| Series 3 Seed | ||||||||
| Series 2 Seed | 340,767 | $0.001326 | $7.07 | $7.07 | 1x | $7.07 | 8.84% | |
| Series 1 Seed | 255,575 | $0.001326 | $7.07 | $7.07 | 1x | $7.07 | 6.63% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Macomics Comparisons
Industry
Financing
Details
Macomics Competitors (57)
One of Macomics’s 57 competitors is Centrose, a Venture Capital-Backed company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| Mestag Therapeutics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| NeoPhore | Venture Capital-Backed | Altrincham, United Kingdom | ||||
| Aronora | Venture Capital-Backed | Portland, OR | ||||
| Meditope Biosciences | Formerly VC-backed | Pasadena, CA |
Macomics Patents
Macomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202415693-D0 | Genetically-engineered cells | Inactive | 24-Oct-2024 | ||
| WO-2026087790-A1 | Genetically-engineered cells | Pending | 24-Oct-2024 | ||
| GB-202314087-D0 | Biomarker for cancer | Inactive | 14-Sep-2023 | ||
| WO-2025056812-A1 | Biomarker for cancer | Inactive | 14-Sep-2023 | ||
| GB-202314086-D0 | Compositions and method for modulation of macrophage activity | Inactive | 14-Sep-2023 |
Macomics Signals
Macomics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| LifeLink Ventures | Venture Capital | Minority | ||
| Old College Capital | Venture Capital | Minority | ||
| Epidarex Capital | Venture Capital | Minority | ||
| Scottish Enterprise | Growth/Expansion | Minority | ||
| The University of Edinburgh | University | Minority |
Macomics FAQs
-
When was Macomics founded?
Macomics was founded in 2018.
-
Where is Macomics headquartered?
Macomics is headquartered in Edinburgh, United Kingdom.
-
What is the size of Macomics?
Macomics has 22 total employees.
-
What industry is Macomics in?
Macomics’s primary industry is Drug Discovery.
-
Is Macomics a private or public company?
Macomics is a Private company.
-
What is the current valuation of Macomics?
The current valuation of Macomics is .
-
What is Macomics’s current revenue?
The current revenue for Macomics is .
-
How much funding has Macomics raised over time?
Macomics has raised $24.6M.
-
Who are Macomics’s investors?
LifeLink Ventures, Old College Capital, Epidarex Capital, Scottish Enterprise, and The University of Edinburgh are 5 of 6 investors who have invested in Macomics.
-
Who are Macomics’s competitors?
Centrose, Mestag Therapeutics, NeoPhore, Aronora, and Meditope Biosciences are some of the 57 competitors of Macomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process